TD Waterhouse Canada Inc. Cuts Holdings in Danaher Co. (NYSE:DHR)

TD Waterhouse Canada Inc. cut its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 20.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 85,710 shares of the conglomerate's stock after selling 21,713 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in Danaher were worth $19,680,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Gilbert & Cook Inc. lifted its position in shares of Danaher by 2.5% during the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate's stock worth $401,000 after acquiring an additional 42 shares in the last quarter. Grimes & Company Inc. lifted its holdings in Danaher by 0.6% during the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate's stock worth $1,696,000 after purchasing an additional 43 shares in the last quarter. Dakota Community Bank & Trust NA boosted its stake in Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate's stock worth $73,000 after purchasing an additional 45 shares during the period. Howard Capital Management Group LLC boosted its stake in Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock worth $342,000 after purchasing an additional 48 shares during the period. Finally, Spinnaker Trust grew its holdings in Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate's stock valued at $988,000 after buying an additional 50 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Robert W. Baird cut their price target on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday. Barclays lifted their price objective on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research note on Tuesday. Citigroup restated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. The Goldman Sachs Group dropped their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday. Finally, Jefferies Financial Group decreased their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $264.40.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 11.10% of the company's stock.

Danaher Stock Up 0.1 %

Shares of NYSE:DHR traded up $0.17 on Thursday, reaching $196.48. The company had a trading volume of 4,453,380 shares, compared to its average volume of 3,353,739. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $140.43 billion, a PE ratio of 37.21, a PEG ratio of 2.66 and a beta of 0.86. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The firm's 50 day simple moving average is $201.01 and its 200-day simple moving average is $225.07.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's dividend payout ratio is currently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.